Clinical Trial Update: Study of NM8074 in Patients With Immunoglobulin A Nephropathy (IgAN) [Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 2 study of NM8074 for IgA nephropathy, which is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iga Nephropathy

Drugs mentioned

• NM8074

Snippet

Sponsor: NovelMed Therapeutics | Conditions: IgA Nephropathy | Phase 2 | Status: NOT_YET_RECRUITING